Why 'Good Enough' Inspection is no longer enough in Stent Manufacturing
In the world of stent manufacturing, 'good enough' has never really been good enough. A stent is implanted inside a human artery. It stays there. The surface finish, the dimensional accuracy, the structural integrity, every parameter matters. And after electropolishing, which is designed to perfect that surface, how confident are you that every stent leaving your line is truly defect-free?
Many manufacturers, the honest answer is: not entirely.
And that's not negligence, it's a limitation of the inspection tools most teams have available.
The Inspection Problem Nobody Talks About
Manual and semi-automated inspection has served the industry for years. But it comes with inherent limitations that become harder to ignore as production volumes grow and regulatory scrutiny increases.
Operator fatigue changes outcomes. Two inspectors looking at the same stent can reach different conclusions. And when you're measuring features in the micron range, which stent quality demands, the human eye, even with magnification, reaches its limits.
The result? Inspection data that's inconsistent, difficult to audit, and nearly impossible to use for meaningful process improvement.
What Purpose-Built Inspection Actually Looks Like
A precision stent inspection system should do more than catch defects. It should:
• Measure all critical dimensions, horizontal, vertical, and angular, in a single automated pass
• Operate without human intervention so results are reproducible, regardless of shift or operator
• Produce structured data that quality teams can actually act on
• Integrate into existing production lines without creating bottlenecks
This is the foundation behind StentSpect-EP, STPLMT's vision inspection system designed specifically for electropolished stents.
Capable of capturing up to 1,400 images in a single scan and completing a full inspection in under 90 seconds, it's built for the realities of modern stent manufacturing, where speed and precision have to coexist.
The SPC Advantage: From Reactive to Proactive Quality
One of the most overlooked benefits of automated inspection isn't what it catches today, it's what it tells you about tomorrow.
StentSpect-EP generates SPC (Statistical Process Control) analytical reports that give quality teams visibility into process trends over time. Instead of simply flagging a non-conforming stent, the system helps identify where in the process a drift is beginning, so manufacturers can intervene before defects become a pattern.
That shift from reactive to proactive quality management is what separates modern inspection from legacy approaches.
Colour-Coded Clarity for Operators
Complex data is only useful if it's actionable. StentSpect-EP presents defect information through colour-coded visual outputs that allow operators to immediately understand what requires attention, without needing deep metrology expertise.
This design choice matters. It reduces the time between inspection and decision, and ensures that the same information is interpreted consistently across shifts.
The real question is how long a team can afford to rely on processes that leave quality outcomes partially in the hands of human variability.
If you're at the point of evaluating or re-evaluating your inspection approach, it's worth understanding what a purpose-built system can do, not just for your quality metrics, but for your confidence in every stent that leaves your facility.